Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Not yet recruiting

HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

NCT07175415

Conditions: Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +19 more
Locations: Not specified

View Trial Details

Not yet recruiting

Risk-adapted Therapeutic Strategy in +1q NDMM

NCT07045168

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: The First Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Not yet recruiting

Ibrutinib Followed by BR (Bendamustine and Rituximab) as a Time-Limited Therapy for Waldenström Macroglobulinemia

NCT07169565

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Not specified

View Trial Details

Not yet recruiting

This is a Phase I/II Interventional, Open-label Treatment Study Designed to Evaluate the Safety and Efficacy of Anti CD 19/22 CAR- T Cells Immunotherapy for Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma.

NCT07162571

Conditions: Acute Lymphobkastic Leukemia, B Cell Lymphoma, Hemic and Lymphatic Diseases, +9 more
Locations: State Institution Minsk Scientific and Practical Center for Surgery, Transplantology, and Dermatology Minsk, Belarus

View Trial Details

Not yet recruiting

Clinico-hematological and Molecular Characteristics of Chronic Lymphocytic Leukemia Patients

NCT07162532

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
Locations: Not specified

View Trial Details

Not yet recruiting

Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT07159906

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Not yet recruiting

Notch 1 Mutation in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patient

NCT07157579

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL)- Non-Hodgins's Lymphoma (NHL), Disease Attributes, +14 more
Locations: Not specified

View Trial Details

Not yet recruiting

Prospective Study of Frontline Antibiotics Therapy in the Treatment of Early-stage HP-negative Gastric MALT Lymphoma

NCT07144657

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: National Taiwan University Hospital Taipei, None Selected, Taiwan

View Trial Details

Not yet recruiting

A Phase I/II Study of TRS005 in Combination With Cyclophosphamide, Doxorubicin, and Prednisone（T-CHP） in Previously Untreated Patients With CD20-positive DLBCL

NCT07035379

Conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Chinese Academy of Medical Sciences, Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Not yet recruiting

Serum Histone Succinylation as a Novel Prognostic Biomarker in Hematological Malignancies

NCT07131449

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Not specified

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions